Frontier Capital Management CO LLC Incyte Corp Transaction History

Frontier Capital Management CO LLC

$9.96 Billion
Q3 2024

A detailed history of Frontier Capital Management CO LLC transactions in Incyte Corp stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 65,959 shares of INCY stock, worth $4.54 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

65,959

Previous 66,651 1.04%

Holding current value

$4.54 Million

Previous $4.04 Million 7.9%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $39,672 - $47,478	-692 Reduced 1.04%	65,959 $4.36 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $27,637 - $34,425	-540 Reduced 0.8%	66,651 $4.04 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $47,897 - $56,401	-847 Reduced 1.24%	67,191 $3.83 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $6,102 - $7,510	117 Added 0.17%	68,038 $4.27 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $39,052 - $44,568	-676 Reduced 0.99%	67,921 $3.92 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $42,665 - $52,857	-700 Reduced 1.01%	68,597 $4.27 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $439,710 - $538,508	-6,261 Reduced 8.29%	69,297 $5.01 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $14,981 - $18,756	-223 Reduced 0.29%	75,558 $6.07 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $26,736 - $33,475	-404 Reduced 0.53%	75,781 $5.05 Million
Q2 2022 Jul 20, 2022	SELL	$66.18 - $83.18 $145,000 - $182,247	-2,191 Reduced 2.8%	76,185 $5.79 Million
Q1 2022 Apr 14, 2022	SELL	$66.02 - $79.71 $19,013 - $22,956	-288 Reduced 0.37%	78,376 $6.23 Million
Q4 2021 Jan 19, 2022	BUY	$63.34 - $74.11 $4.98 Million - $5.83 Million	78,664 New	78,664 $5.77 Million
Q3 2021 Oct 19, 2021	SELL	$68.67 - $84.02 $38.1 Million - $46.6 Million	-554,960 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$79.87 - $87.53 $5.73 Million - $6.28 Million	-71,708 Reduced 11.44%	554,960 $46.7 Million
Q1 2021 May 13, 2021	BUY	$76.02 - $100.5 $6.84 Million - $9.04 Million	89,957 Added 16.76%	626,668 $50.9 Million
Q4 2020 Jan 19, 2021	SELL	$80.74 - $97.7 $14.4 Million - $17.5 Million	-178,717 Reduced 24.98%	536,711 $46.7 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $2.77 Million - $3.57 Million	-32,558 Reduced 4.35%	715,428 $64.2 Million
Q2 2020 Jul 17, 2020	SELL	$74.18 - $108.93 $3.14 Million - $4.62 Million	-42,393 Reduced 5.36%	747,986 $77.8 Million
Q1 2020 Apr 16, 2020	SELL	$63.18 - $85.97 $7.57 Million - $10.3 Million	-119,870 Reduced 13.17%	790,379 $57.9 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $31.5 Million - $41.3 Million	431,135 Added 89.99%	910,249 $79.5 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $4.28 Million - $5.09 Million	-58,780 Reduced 10.93%	479,114 $35.6 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $38.6 Million - $46.6 Million	-524,996 Reduced 49.39%	537,894 $45.7 Million
Q1 2019 May 07, 2019	BUY	$63.56 - $88.17 $19.3 Million - $26.7 Million	303,029 Added 39.88%	1,062,890 $91.4 Million
Q4 2018 Jan 25, 2019	SELL	$58.5 - $69.94 $19.3 Million - $23 Million	-329,100 Reduced 30.22%	759,861 $48.3 Million
Q3 2018 Oct 30, 2018	BUY	$61.75 - $74.23 $5.72 Million - $6.87 Million	92,602 Added 9.29%	1,088,961 $75.2 Million
Q2 2018 Aug 03, 2018	BUY	$60.85 - $83.98 $36 Million - $49.7 Million	592,132 Added 146.49%	996,359 $66.8 Million
Q1 2018 Apr 30, 2018	SELL	$83.06 - $100.98 $36 Million - $43.8 Million	-434,019 Reduced 51.78%	404,227 $33.7 Million
Q4 2017 Jan 18, 2018	SELL	$93.56 - $116.6 $5.42 Million - $6.76 Million	-57,983 Reduced 6.47%	838,246 $79.4 Million
Q3 2017 Oct 31, 2017	BUY	$109.15 - $138.27 $97.8 Million - $124 Million	896,229	896,229 $105 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account

Frontier Capital Management CO LLC Incyte Corp Transaction History